Trials / Unknown
UnknownNCT03527134
Effects of Amantadine on Postoperative Cognitive Dysfunction
Effects of Amantadine on Postoperative Cognitive Dysfunction in Elderly Patients With Elective Abdominal Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 390 (estimated)
- Sponsor
- Zhiyi Zuo · Academic / Other
- Sex
- All
- Age
- 60 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
Post-operative cognitive dysfunction (POCD) is a fairly well-documented clinical phenomenon. Investigators will determine whether amantadine can reduce the occurrence of POCD in elderly patients with major abdominal surgery.
Detailed description
Patients who are 60 years old or older for laparoscopic abdominal surgery will be randomly assigned into two groups: 1) no-treatment group, and 2) amantadine-treated group. Each group will have 150 patients. In addition, investigators will need 90 subjects in the control group. The data of these control subjects will be used to normalize the data of the two studied groups to diagnose POCD. The subjects in control groups will also be elderly but without the exposure to anesthesia and surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amantadine | patients will receive amantadine 100 mg by month 2 h before the induction of general anesthesia and then 100 mg each time, three times per day for 5 days. |
Timeline
- Start date
- 2019-04-30
- Primary completion
- 2021-07-01
- Completion
- 2021-10-01
- First posted
- 2018-05-17
- Last updated
- 2019-01-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03527134. Inclusion in this directory is not an endorsement.